Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Dermatology

The Melasma Mistake Indian Women Keep Making That Makes Pigmentation Permanently Worse

Why Melasma Behaves Differently on Indian SkinMelasma on Fitzpatrick Type IV and V skin, which covers most Indian women, sits deeper in the dermis than it does on lighter skin tones. A 2020 study published in the Indian Journal of Dermatology confirmed that Indian patients show a higher proportion of…

Times Life

AHA vs BHA: What Each Acid Actually Does and Which Indian Skin Types Need More

Two acids, two completely different jobsAHA stands for alpha hydroxy acid. BHA stands for beta hydroxy acid. Both are chemical exfoliants, but they work on different layers of skin and target different problems. AHA is water-soluble. It works on the surface, dissolving the bonds that hold dead skin cells together…

Times Life

Niacinamide and Indian Skin: Why Pigmentation Responds Differently and How to Use It Right

What Niacinamide Actually Does at the Cellular LevelNiacinamide, vitamin B3, works by blocking the transfer of melanosomes from melanocytes to keratinocytes. A 2002 study published in the British Journal of Dermatology by Hakozaki et al. showed that a 5% niacinamide formulation reduced hyperpigmentation and improved skin toning in Japanese women…

Times Life

From analysis to the latest developments in health,
read the most diverse news in one place.

The Beauty Minimalism Trend That Actually Works for Indian Skin and Melanin-Rich Complexions

Why Indian skin gets left out of the minimalism conversationThe global minimalist beauty movement arrived with a specific skin type in mind: pale, dry, and prone to sensitivity in cold climates. The three-step routines promoted by Scandinavian and Korean-adjacent brands, gentle cleanser, lightweight moisturiser, SPF, were built for skin that…

Times Life

How the Skincare Industry Sells You More Products Than You Need and How to Push Back

The Ten-Step Routine Was Never About Your SkinThe average Indian woman in her twenties owns more skincare products than she will finish in two years. That is not a coincidence. The ten-step routine, popularised by Korean beauty marketing and amplified by Indian influencers, was never a dermatological recommendation. It was…

Times Life

How Homegrown Indian Beauty Brands Are Finally Formulating for Indian Skin

The Shelf Was Never Built for YouWalk into any chemist in Bengaluru or Bhopal and the anti-ageing aisle still skews heavily toward brightening serums designed for skin that tans minimally and ages with fine lines rather than hyperpigmentation. That was not an accident. For most of the post-liberalisation era, the…

Times Life

6 Signs Your Hair Is Actually Healthy and You Don't Even Know It

For years, beauty culture created a very specific image of what “healthy hair” supposedly looks like. Perfectly smooth strands. No frizz. Endless shine. Hair moving dramatically in slow motion like it just signed a luxury shampoo contract. But real hair does not behave like edited content online. Lighting, filters, extensions,…

MyLifeXP

Read news from The Economist, FT, and more,
with one subscription

A Fungal Pathogen That Can Destroy Vision Triggered a Clinic Outbreak Linked to Eye Procedures — A New CDC MMWR Investigation Published This Week Exposes a Critical Gap in Ophthalmic Safety

CDC MMWR (January/June 2026): Purpureocillium lilacinum keratitis was linked to an ophthalmology clinic in New York City (2024) and a pseudo-outbreak at a dermatology clinic in Washington. P. lilacinum is an antifungal-resistant mold that can cause permanent vision loss. Here is what patients and clinicians need to know.

Medical Daily

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of positive topline results from its Phase II randomized, double-blind, placebo-controlled trial of CG2001 at the 14th World Congress for Hair Research (WCHR) in Seoul, South…

AAP

5 Tanning Mistakes Most People Make Every Summer

Summer often brings a certain pressure to look glowing, bronzed, and camera-ready. Social media, travel culture, and beauty trends have made tanning feel like a normal part of the season for many young people. Yet despite how common tanning is, many individuals still misunderstand how sun exposure actually affects the…

MyLifeXP

It costs $230 out-of-pocket to see a dermatologist. Many Australians go without – despite soaring skin cancer rates

Exclusive: Report shows cost of first appointment rose $20 in one year, with steeper rises in Western Australia, South Australia and Tasmania

The Guardian - AU

‘Vaginal estrogen as a face filler? I think not’: Experts critique the new skincare trend

Doctors warn viral off-label use lacks evidence, with unknown long-term risks and possible systemic absorption

The Guardian - US

Millions possibly affected by data breach at dermatology giant QualDerm

QualDerm is notifying people about a data breach which exposed their personal and health information.

TechRadar

This Under-the-Radar Stock Has Surged 1,300% Over the Past Year

Sol-Gel Technologies (SLGL) is a clinical-stage dermatology company focused on topical drugs for skin diseases. SLGL demonstrates exceptional technical momentum and is up 1,310% over the past 52 weeks. The stock set a new three-year high earlier in March. Despite strong price action, SLGL remains highly speculative and unproven. Today’s...

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Times Pets

India’s Pet Boom: Why More Indians Are Opening Their Homes and Hearts to Pets

Over the last decade, something beautiful has been happening in Indian homes. More families are welcoming pets not just as animals but as members of the family. From busy metro cities to smaller towns, the sight of dogs going on evening walks or cats curling up on balconies has become…

Marie Claire

This At-Home Acne Injection Pen Could Revolutionise Treatment—But Dermatologists Have Reservations

The Indomo ClearPen is yet to be approved in the UK, but the founders hope for future availability

MyLifeXP

2026 Beauty Revolution: Minimal Routines, Maximum Results with Skinimalism 2.0

The Rise of Skinimalism 2.0 Beauty routines have traditionally been complex, with multiple serums, toners, and creams promising transformative results. However, modern lifestyles are changing how people approach skincare. Busy schedules, increased awareness of skin health, and environmental. concerns have led to a shift toward simpler, more effective routines. It…

International Business Times UK

Kanye West Claims Bianca Censori Must Look Like a Mannequin — No Flaws, No Marks

Bianca Censori's dermatology incident and reports of Kanye West's 'mannequin-like' beauty rules fuel new debate about the pair's public image.

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times

The New Face of Dermatology: How Telemedicine is Transforming Patient Care

In the evolving landscape of healthcare, Gigi Rusnak, MSN, FNP-C, DCNP, is at the forefront of a shift that's redefining how skin health is treated and how patients are cared for.

Benzinga

Why Is Nektar Therapeutics Stock Trading Higher On Thursday? (CORRECTED)

Editor’s Note: This article has been updated to correct an earlier inaccuracy regarding the company’s stock trajectory.

Marie Claire

Marie Claire UK Skin Awards 2025: Meet the Visionary Judges Defining the Best in Beauty

The skincare elite

Benzinga

Why Is Sanofi Stock Falling Thursday?

On Thursday, Sanofi SA (NASDAQ:SNY) stock tumbled after late-stage trial results for amlitelimab, its potential successor to blockbuster eczema drug Dupixent, failed to match investor expectations, raising fresh doubts about the company’s ability to sustain its dermatology franchise once patent protections expire.

Benzinga

Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors

French drugmaker Sanofi SA (NASDAQ:SNY) stock fell sharply Thursday after late-stage trial results for amlitelimab, its potential successor to blockbuster eczema drug Dupixent, failed to match investor expectations, raising fresh doubts about the company’s ability to sustain its dermatology franchise once patent protections expire.

Marie Claire

Decoding the Skin-Brain Axis: How Dermatology and Neuroscience Are Converging

The microbiome’s hidden impact on mood

Marie Claire

Forget Expensive Dermatology Appointments, It’s So Easy To Get Help With This New Skin Service At Boots

Accessible advice for everyday skin concerns

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.